AI-designed “intrabodies” could unlock new treatments for Alzheimer’s, Parkinson’s and MND
Researchers have developed a new way to turn ordinary antibodies into tiny disease-fighting molecules that can work inside human cells, potentially opening new paths for treating Alzheimer’s, Parkinson’s, Huntington’s disease,…
FDA panel recommends controversial treatments
A controversial new FDA panel recommendation could affect the sale of peptides—popular treatments marketed for benefits ranging from muscle growth to weight loss. NBC News’ Anne Thompson explains why not…







